Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcutaneous Electrical Nerve Stimulation (TENS) for IUD Insertion Pain

NCT: NCT06245655 · COMPLETED

NCT IDNCT06245655
StatusCOMPLETED
Start Date2024-03-25
Completion2025-04-21
SponsorIcahn School of Medicine at Mount Sinai (OTHER)
First posted
Last updated

Brief Summary

This study is a double-blind, randomized, placebo-controlled trial to evaluate the use of high frequency TENS for pain control during IUD insertion. Transcutaneous electrical nerve stimulation (TENS) is a relatively low-cost, low-risk, non-pharmacologic intervention for pain management. Previous studies have found that TENS reduces pain associated with other outpatient gynecological procedures. Participants will be randomized in a 1:1 ratio to either active treatment or placebo (placebo TENS) and record pain scores using a 100 mm visual analog scale (VAS) at the time of IUD insertion. The same device will be used for both active and placebo treatment.

Frequently Asked Questions

What is Transcutaneous Electrical Nerve Stimulation (TENS) for IUD Insertion Pain?

Transcutaneous Electrical Nerve Stimulation (TENS) for IUD Insertion Pain is a clinical trial registered under NCT06245655. Current status: COMPLETED.

What is the status of NCT06245655?

The current status of NCT06245655 (Transcutaneous Electrical Nerve Stimulation (TENS) for IUD Insertion Pain) is: COMPLETED.

When did Transcutaneous Electrical Nerve Stimulation (TENS) for IUD Insertion Pain start?

Transcutaneous Electrical Nerve Stimulation (TENS) for IUD Insertion Pain started on 2024-03-25.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.